Coronavac COVID-19 vaccine safe in children and adolescents and triggers antibodies
Public opinion surveys on vaccine hesitancy can help predict where vaccine uptake is likely to be lower
28 June 2021US emerging from pandemic, but COVID will cast a long shadow on American health
29 June 2021Coronavac COVID-19 vaccine safe in children and adolescents and triggers antibodies
Two doses of CoronaVac are safe and provoke a strong antibody response among children and adolescents aged 3-17 years, according to a randomised controlled trial of 550 young people published in The Lancet Infectious Diseases journal.
